European Commission introduces presumption of harm to innovation requiring intrusive remedies as a price for clearance in innovative industries, and warns that institutional investor cross-shareholdings are presumed to dampen price and innovation competition.
EU Merger Control: the Dow/DuPont Theory of Innovation Harm
Bill Batchelor et al., Baker McKenzie Client Alert, October 2017
Click here to read the full article online
publications
Download our brochure 
© 2018 - Concurrences